Publications by authors named "M I Delday"

Neurodegenerative diseases are disabling, incurable, and progressive conditions characterized by neuronal loss and decreased cognitive function. Changes in gut microbiome composition have been linked to a number of neurodegenerative diseases, indicating a role for the gut-brain axis. Here, we show how specific gut-derived bacterial strains can modulate neuroinflammatory and neurodegenerative processes through the production of specific metabolites and discuss the potential therapeutic implications for neurodegenerative disorders.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the protective effects of Bacteroides thetaiotaomicron, a beneficial gut bacteria, against inflammatory bowel disease (IBD), particularly Crohn's disease, in rodent models.
  • B. thetaiotaomicron treatment significantly improved symptoms of IBD, such as weight loss and colon damage, through both live bacteria and freeze-dried formulations, as well as a specific protein that reduced inflammation.
  • The findings suggest that B. thetaiotaomicron and its products could be promising new alternatives for treating Crohn's disease and improving gut health.
View Article and Find Full Text PDF

Asthma is a phenotypically heterogeneous disease. In severe asthma, airway inflammation can be predominantly eosinophilic, neutrophilic, or mixed. Only a limited number of drug candidates are in development to address this unmet clinical need.

View Article and Find Full Text PDF

Objective: is a flagellated gut anaerobic bacterium belonging to the family within the Firmicutes phylum. A significant decrease of colonization in the gut of ulcerative colitis patients has recently been demonstrated. In this work, we have investigated the mechanisms of -host cross talk using both murine and models.

View Article and Find Full Text PDF